Preclinical and clinical safety data includes [5] : No evidence of mutagenic activity, chromosomal aberrations, or micronucleus formation in genotoxicity studies 6-month chronic oral administration studies in rats showed no toxicological concerns 9-month studies in cynomolgus monkeys revealed general safety Six human clinical trials spanning 0.25 mg to 30 mg doses for up to 6 months No serious adverse events or withdrawals related to AOD9604 intake No anti-AOD9604 antibodies detected, indicating low immunogenic potential No changes in vital signs, physical examinations, electrocardiograms, or safety-related laboratory parameters Research Applications A Quick Review AOD9604 is a peptide compound that has shown potential in research related to lipid metabolism, energy balance, and tissue regeneration
Potential tissue repair properties in animal models
The size of a container is not the best way to measure a drink
Altered Cbl metabolism due to genetic variations may affect DNA methylation, gene expression, and the overall health of nerve cells, potentially influencing the risk and outcomes of MS
PloS Genet
Carvalho, E., Kotani, K., Peroni, O